New Del. Law Can't Invalidate Genelux Stock, Court Says

A Delaware court has ruled against biopharmaceutical company Genelux Corp. in its feud over company control, finding stock issued to founder Aladar Szalay is valid and upholding his appointment of two...

Already a subscriber? Click here to view full article